GTx Inc (GTXI) - Financial and Strategic SWOT Analysis Review

Date: June 28, 2017
Pages: 46
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: GB671E5DB51EN
Leaflet:

Download PDF Leaflet

GTx Inc (GTXI) - Financial and Strategic SWOT Analysis Review
GTx Inc (GTXI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

GTx Inc (GTx) is a biopharmaceutical company that discovers, develops and commercializes novel targeted hormonal therapies. It develops small molecules that targets hormone pathways for the treatment of various cancers including breast and prostate cancer; and other serious medical conditions. The company is further focused on developing selective androgen receptor modulators (SARMs), a class of drugs that have the potential to be used as a hormonal therapy for treating advanced breast cancer and other serious medical conditions, such as stress urinary incontinence (SUI) and Duchenne muscular dystrophy (DMD). GTx is developing enobosarm, a SARM in Phase II trials for treating breast cancer and stress urinary incontinence. GTx is headquartered in Memphis, Tennessee, the US.

GTx Inc Key Recent Developments

May 15,2017: GTx Provides Corporate Update and Reports First Quarter 2017 Financial Results
Mar 15,2017: GTx Provides Corporate Update and Reports Fourth Quarter and Year-End 2016 Financial Results
Nov 03,2016: GTx Provides Corporate Update and Reports Third Quarter 2016 Financial Results
Sep 01,2016: GTx Appoints Dr. Garry Neil to Board of Directors
Aug 09,2016: GTx Provides Corporate Update and Reports Second Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

GTx Inc - Key Facts
GTx Inc - Key Employees
GTx Inc - Key Employee Biographies
GTx Inc - Major Products and Services
GTx Inc - History
GTx Inc - Company Statement
GTx Inc - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

GTx Inc - Business Description
GTx Inc - SWOT Analysis
SWOT Analysis - Overview
GTx Inc - Strengths
GTx Inc - Weaknesses
GTx Inc - Opportunities
GTx Inc - Threats
GTx Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

GTx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
GTx Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
GTx Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 15, 2017: GTx Provides Corporate Update and Reports First Quarter 2017 Financial Results
Mar 15, 2017: GTx Provides Corporate Update and Reports Fourth Quarter and Year-End 2016 Financial Results
Nov 03, 2016: GTx Provides Corporate Update and Reports Third Quarter 2016 Financial Results
Sep 01, 2016: GTx Appoints Dr. Garry Neil to Board of Directors
Aug 09, 2016: GTx Provides Corporate Update and Reports Second Quarter 2016 Financial Results
May 10, 2016: GTx Provides Corporate Update and Reports First Quarter 2016 Financial Results
Mar 03, 2016: GTx Provides Corporate Update and Reports Fourth Quarter and Year-End 2015 Financial Results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

GTx Inc, Key Facts
GTx Inc, Key Employees
GTx Inc, Key Employee Biographies
GTx Inc, Major Products and Services
GTx Inc, History
GTx Inc, Key Competitors
GTx Inc, Ratios based on current share price
GTx Inc, Annual Ratios
GTx Inc, Annual Ratios (Cont...1)
GTx Inc, Interim Ratios
GTx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
GTx Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
GTx Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

GTx Inc, Performance Chart (2012 - 2016)
GTx Inc, Ratio Charts
GTx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
GTx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Takeda Pharmaceutical Company Ltd
Radius Health Inc
Novartis AG
Merck & Co Inc
Incyte Corp
F. Hoffmann-La Roche Ltd
Curadis GmbH
Astellas Pharma Inc
Skip to top


Ask Your Question

GTx Inc (GTXI) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: